Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 197.77 -0.01 (-0.01%) Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 707,810 Open 199.14 Bid (Size) 193.42 (1) Ask (Size) 202.19 (1) Prev. Close 197.78 Today's Range 195.76 - 200.52 52wk Range 161.65 - 275.00 Shares Outstanding 50,396,622 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Charles River Launches New Retrogenix® Non-Human Protein Library October 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call October 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Performance YTD -15.57% -15.57% 1 Month -4.04% -4.04% 3 Month -9.38% -9.38% 6 Month -12.79% -12.79% 1 Year +5.53% +5.53% More News Read More This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday October 07, 2024 Via Benzinga Evaluating Charles River: Insights From 12 Financial Analysts October 07, 2024 Via Benzinga The Analyst Verdict: Charles River In The Eyes Of 10 Experts September 20, 2024 Via Benzinga Critical Insights From Charles River Analyst Ratings: What You Need To Know August 08, 2024 Via Benzinga This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday October 07, 2024 Via Benzinga Charles River Provides Translational Expertise at Neuroscience 2024 October 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease October 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research September 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio? September 08, 2024 Via Benzinga Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience September 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Baird and Morgan Stanley Conferences September 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers August 31, 2024 Via Benzinga Topics Stocks Exposures US Equities CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm August 13, 2024 From Bragar Eagel & Squire Via GlobeNewswire Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? August 11, 2024 Via Benzinga EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway August 08, 2024 Via Benzinga Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday August 08, 2024 Via Benzinga Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close August 07, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast August 07, 2024 Via Benzinga Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 August 07, 2024 Via Investor's Business Daily Charles River Laboratories Announces Second-Quarter 2024 Results August 07, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development July 30, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery July 24, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call July 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
